Archives Catalogue

File includes two presentations of the research findings: at the Canadian Association of Health Services and Policy Research Conference in Montreal, September 16-18, 2005; and at the Conference at the Centre for Health Services and Policy Research (CHSPR), UBC, February 9-10, 2006.

Cost-effectiveness of multiple sclerosis - DMT report and notes

MS-2-802, Box 8, Folder 12
File
2005

Part of Murray G. Brown fonds

Cost-effectiveness of MS DMDs in Nova Scotia - abstract, tables, draft stucture, notes

MS-2-802, Box 19, Folder 4
File
2010

Part of Murray G. Brown fonds

Cost-effectiveness of Interferon Beta-1B in slowing multiple sclerosis disability progression : first estimates

MS-2-802, Box 23, Folder 6
File
1996, 2000

Part of Murray G. Brown fonds

File includes a one-page summary and an offprint of an overview based in part on the CCOHTA study conducted by Murray Brown et al.

Cost-effectiveness of disease modifying therapies that slow disability progression in relapsing remitting and secondary progressive multiple sclerosis - DO files

MS-2-802, Box 8, Folder 7
File
2005

Part of Murray G. Brown fonds

Cost-effectiveness and cost-effectiveness-acceptibility-curves for therapies that slow disability progression in relapsing-remitting multiple sclerosis : simulations for US and Canadian markets - draft report and correspondence for Aventis Pharmaceuticals

MS-2-802, Box 4, Folder 11
File
2003

Part of Murray G. Brown fonds

Cost-effectiveness : the case of home health care physician services in New Brunswick, Canada

MS-2-802, Box 12, Folder 3
File
1995

Part of Murray G. Brown fonds

Cost of multple sclerosis study correspondence, data tables, research notes, reports, abstracts and meeting notes

MS-2-802, Box 4, Folder 9
File
1994-1995

Part of Murray G. Brown fonds

Cost of multiple sclerosis study tables, notes and correspondence

MS-2-802, Box 4, Folder 4
File
2000-2001

Part of Murray G. Brown fonds

Cost of multiple sclerosis study research presentations for symposiums, offprint, data entry forms

MS-2-802, Box 2, Folder 15
File
1996-1999

Part of Murray G. Brown fonds

Cost of multiple sclerosis study proposal, notes and correspondence

MS-2-802, Box 4, Folder 5
File
1995

Part of Murray G. Brown fonds

Cost of multiple sclerosis study meeting minutes with appendices on costing methods and plans

MS-2-802, Box 2, Folder 1
File
1998

Part of Murray G. Brown fonds

Cost of multiple sclerosis study correspondence, data tables and notes

MS-2-802, Box 4, Folder 10
File
1999-2000

Part of Murray G. Brown fonds

Correspondence, notes, drafts and tables for a study on the impact of universal medicare on the previously insured poor and non-poor

MS-2-802, Box 15, Folder 5
File
1985

Part of Murray G. Brown fonds

Correspondence, notes and application for Health Technology Assessment (HTA) grant for Credibility of HTA results for new chronic disease therapies : a case study of MS drugs

MS-2-802, Box 2, Folder 14
File
2004

Part of Murray G. Brown fonds

Correspondence, funding applications and reports for research regarding physicians services in Nova Scotia

MS-2-802, Box 3, Folder 6
File
1973

Part of Murray G. Brown fonds

Correspondence, budget statements, applications, and reports regarding project funding in Dalhousie's Department of Preventative Medicine

MS-2-802, Box 3, Folder 5
File
1973-1977

Part of Murray G. Brown fonds

Correspondence, applications and reports regarding project funding and funding strategies in Dalhousie's Department of Preventative Medicine

MS-2-802, Box 3, Folder 3
File
1974-1975

Part of Murray G. Brown fonds

Correspondence, abstracts and notes regarding proposal to the Canadian Coordinating Office for Health Technology Assessment (CCOHTA) for a symposium on multiple sclerosis

MS-2-802, Box 16, Folder 6
File
1998-2001

Part of Murray G. Brown fonds

Correspondence with Helen Tremlett and data tables regarding EDSS in natural history of MS

File
2009

Part of Murray G. Brown fonds

Correspondence with Francois Blanchette regarding impact of DMDs on MS disease progression

MS-2-802, Box 8, Folder 9
File
2005

Part of Murray G. Brown fonds

Correspondence with Bjorn Runmarker regarding natural history and treatment of multiple sclerosis

MS-2-802, Box 18, Folder 4
File
1995

Part of Murray G. Brown fonds

Correspondence regarding Dalhousie and Capital Health appointments

MS-2-802, Box 22, Folder 3
File
1973 - 2020

Part of Murray G. Brown fonds

Correspondence regarding appointments, reviews, and presentations

MS-2-802, Box 19, Folder 14
File
1973 - 1992

Part of Murray G. Brown fonds

File consists of various correspondence regarding appointments, reviews, conferences, and presentations.

Correspondence regarding the directorship of the Population Health Research Unit

MS-2-802, Box 26, Folder 13
File
1995

Part of Murray G. Brown fonds

Correspondence re. office/research space and post-retirement status

MS-2-802, Box 19, Folder 2
File
2012

Part of Murray G. Brown fonds

Correspondence from L. Metz with publication plan, draft reports and data files for cost of multiple sclerosis study

MS-2-802, Box 2, Folder 3
File
1999

Part of Murray G. Brown fonds

Correspondence between Murray Brown and Sandra McGuinness regarding cost of multiple sclerosis study updates

MS-2-802, Box 2, Folder 2
File
1998

Part of Murray G. Brown fonds

Correspondence and reports regarding Biogen / Axia Research

MS-2-802, Box 26, Folder 14
File
2006

Part of Murray G. Brown fonds

Correspondence and proposal for multiple sclerosis prevalence study, including withdrawal of participation

MS-2-802, Box 2, Folder 13
File
2003

Part of Murray G. Brown fonds

Consultation report regarding cost-effectiveness of a prenatal screening survey for hepatitis B surface antigen at Grace Maternity Hospital, Halifax, Nova Scotia

MS-2-802, Box 26, Folder 1
Item
1990

Part of Murray G. Brown fonds

Item includes a covering letter from Murray Brown.

Conference schedule for MS research presentations

MS-2-802, Box 26, Folder 16
Item
2001

Part of Murray G. Brown fonds

Item is a spreadsheet of dates, conference meetings, authors and paper titles.

Complete cost of multiple sclerosis study materials template with methodology documentation and commentary

MS-2-802, Box 2, Folder 4
File
[1989]

Part of Murray G. Brown fonds

Community health services in St. Andrews : a report by Murray G. Brown and Charles S. Redden

MS-2-802, Box 25, Folder 5
Item
1982

Part of Murray G. Brown fonds

Item is a report commissioned by the St. Andrews Town Council.

Community health and epidemiology work-in-progress seminar presentation on multiple sclerosis research

MS-2-802, Box 18, Folder 8
File
1995

Part of Murray G. Brown fonds

Community health and epidemiology : preliminary evaluation of the New Brunswick extra-mural hospital

MS-2-802, Box 24, Folder 6
Item
1990

Part of Murray G. Brown fonds

Item is a report by Murray Brown, Franklin M.M. White, Lucy Wynn, David Hogan, A. Peter Ruderman and G. Ross Baker.

Community health and epidemiology : effectiveness of high-risk cholesterol and multifactoral public health strategies in reducing coronary heart disease

MS-2-802, Box 24, Folder 5
Item
1991

Part of Murray G. Brown fonds

Item is a study report by Murray Brown, Donald Langille and David MacLean.

Clinical effectiveness of disease modifying treatment (DMT) that delays disability progression in relapsing/remitting-onset MS

MS-2-802, Box 23, Folder 2
File
2005 - 2006

Part of Murray G. Brown fonds

File includes two (PowerPoint) presentations of the research findings: at the DMSRU Study Group seminar on 14 December 2005; and at UBC Department of Neurology on February 8, 2006.

Clinical effectiveness of disease modifying therapies that slow disability progression in relapsing/remitting-onset multiple sclerosis : 'real world' evidence from Nova Scotia - MSID corrections and correspondence, results tables